GlassScriptPhysician profile
Andrew M Monfee
NPI 1447257142
$794.31
in general payments reported to CMS, 2019-2025
17 companies · $51.47 in 2025
The $51.47 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $181 · 2021: $133 · 2022: $113 · 2023: $81.71 · 2024: $97.25 · 2025: $51.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $240.80 | 2019-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $162.32 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $122.13 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Amarin Pharma, INC. | $59.96 | 2020 | |
| Abbott Laboratories | $26.47 | 2021-2023 | Freestyle Libre |
| Sunovion Pharmaceuticals INC. | $23.49 | 2019 | |
| Hologic Sales and Service, LLC | $18.59 | 2024 | Aptima, Thinprep 2000 Processor |
| Adlon Therapeutics L.P. | $17.75 | 2021 | |
| Pfizer INC. | $16.44 | 2022 | |
| Mylan Specialty L.P. | $16.36 | 2024 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $13.82 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.82 | 2021 | |
| Astellas Pharma US INC | $13.38 | 2024 | Veozah |
| Agile Therapeutics, INC. | $13.36 | 2021 | |
| Glaxosmithkline, LLC. | $11.97 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.91 | 2020 | |
| Therapeuticsmd, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Monfee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.